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on activation, and then transmigrates through the endothelium. In this study, we simulate the transition to ﬁrm adhesion via
chemokine-induced integrin activation. To recreate the transition from rolling to ﬁrm adhesion, we use an integrated signaling
adhesive dynamics simulation that includes selectin, integrin, and chemokine interactions between the cell and an adhesive
substrate. Integrin bonds are of low afﬁnity until activated by chemokine binding to G-protein coupled receptors on the model
cell. The signal propagates within the cell through probabilistic diffusion and reaction of the signaling elements to induce the
high-afﬁnity integrins required for ﬁrm adhesion. This model showed that integrins become progressively active as cells roll
and interact with chemokines, leading to a slight slowing before ﬁrm adhesion on a timescale similar to that observed in
experiments. Increasing the density of chemokine resulted in decreases in the rolling time before stopping, consistent with exper-
imental observations. However, a limit is reached where further increases in chemokine density do not increase adhesion. We
found that the timescale for integrin activation correlated with the time to stop. Further, altering parameters within the intracellular
signaling cascade that changed the speed of integrin activation, such as effector activation and dissociation rates, correspond-
ingly affected the time to ﬁrm adhesion. For all conditions tested, the number of active integrin bonds at the point of ﬁrm adhesion
was relatively constant. Themodel predicts that the time to stop would be relatively independent of selectin or integrin density, but
strongly dependent on the shear rate because higher shear rates limit the intrinsic activation rate of integrins and require more
integrins for adhesion.INTRODUCTIONAt sites of inflammation in the body, neutrophils flowing in
the blood stream are captured by selectin adhesion molecules
upregulated on inflamed endothelium and begin to roll. After
a period of selectin-mediated rolling, the cells stop and firmly
adhere to the vessel wall, followed by extravasation to the
unhealthy tissue via morphological changes and crawling
through the endothelium. Firm adhesion at an inflammatory
site, mediated by activation of the integrin lymphocyte func-
tion-associated antigen-1 (LFA-1) (1), is an essential step in
this process.
LFA-1 and other b2-integrins bind to intracellular adhesion
molecule-1 (ICAM-1). Under resting conditions, wild-type
LFA-1 is predominantly in a low-affinity state, but a higher-
affinity state is required for firm adhesion (2–4). The change
to a high-affinity state is believed to require a conformational
change; integrinaVb3 has been visualized by electronmicros-
copy with various degrees of extension, a characteristic likely
also exhibited by LFA-1 (5,6). Furthermore, the I-domain
fragment of LFA-1, which binds ICAM-1, can adopt different
conformations and affinities for binding ICAM-1 (7,8). Thus,
integrins can modulate their affinity during inflammation. To
study firm adhesion in vitro, experimentalists have activated
integrins by the addition of cations (9,10), mutations in the
I-domain that lock it in a given conformation (11), or binding
it with activating antibodies (12).Submitted May 20, 2008, and accepted for publication December 5, 2008.
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0006-3495/09/04/2989/16 $2.00In vivo, integrins are activated by outside-in signaling
through selectins (13) or exposure to inflammatory chemo-
kines (14,15). Many in vitro experiments have been carried
out in flow chambers to study cell activation by chemokines.
Sometimes, a soluble chemokine is applied in the fluid-phase
and, generally, these cells are rapidly activated before adhe-
sion under flow (16,17). In other experiments, chemokine
molecules may be immobilized on the adhesive surface to
which the cells subsequently adhere (14,15,18) or expressed
on cultured endothelial cells stimulated to mimic inflamma-
tory conditions (19–21). In these experiments, leukocytes are
activated, but the speed of activation and firm adhesion
seems to differ with the cell type, the densities of chemokine
and adhesion molecules, and the flow rate. For example,
DiVietro et al. (18) have recreated the transition from rolling
to firm adhesion in a flow chamber. They coated the reactive
surface with P-selectin, the integrin ligand ICAM-1, and the
chemokine interleukin-8 (IL-8), and showed that neutrophils
rolled and then slowed to a stop on this minimal surface, re-
porting how the time to stop decreases as a function of
increasing chemokine density. They showed the timescale
of neutrophil activation could decrease from 117 to 30 s
when the density of IL-8 increased from 60 to 350 sites/
mm2 on a surface that also contained P-selectin and ICAM-1.
Our goal is to develop a calculus to predict the activation
and adhesion by leukocytes in response to immobilized
chemokine. In this study, we modify the adhesive dynamics
model developed previously in our lab (22–25) to study the
initial firm adhesion of a neutrophil after a period of rolling.doi: 10.1016/j.bpj.2008.12.3930
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FIGURE 1 Model schematics. (A) The interactions
important to the Adhesive Dynamics module are shown.
The reactive surface displays three molecules that can
bind to cell-surface molecules. In the model, the cell-
surface molecules are on the tips of cylindrical protrusions
that can stretch like microvilli, but here, the cell is depicted
without microvilli for clarity. PSGL-1 on the cell binds to
P-selectin on the reactive surface whereas CXCR1 binds to
IL-8. A signaling cascade (B) can lead to activation of
LFA-1 on the cell. Both inactive and active LFA-1 can
bind to ICAM-1 on the surface, but the active form has
a higher affinity. (B) The steps in the signaling module
are demonstrated. Transmembrane G-protein molecules
in a microvillus can diffuse and bind to CXCR1 at the
microvillus tip. When CXCR1 is bound to IL-8 extracellularly, the associated G-protein can become active, dividing into two subunits, a and bg, that can
then diffuse within the membrane. The bg subunit can bind with a diffusing Effector molecule and activate it. The active Effector can then diffuse and
bind to the intracellular portion of LFA-1, thereby activating it.
2990 Caputo and HammerAdhesive dynamics is a mechanically rigorous dynamic
simulation of cell adhesion that models adhesion molecules
as reactive springs. The motion and adhesion of a cell results
from a force and torque balance. Bond formation and force-
driven breakage are calculated by random number sampling
of probability functions. This method has calculated the roll-
ing of leukocytes (23,24,26–29), the detachment of cells
from surfaces (30,31), and the firm adhesion of leukocytes
(23,24). Recently, we developed a class of simulation
referred to as integrated signaling adhesive dynamics
(ISAD), where signaling pathways and adhesion are inter-
connected. A version of ISAD was reported in which
a mitogen-activated protein kinase (MAPK) pathway initi-
ated by selectin ligation resulted in integrin activation and,
consequently, a transition from rolling to firm adhesion
(25,32). However, we currently believe that chemokine
ligation is the predominant mechanism of adhesion in leuko-
cyte systems—including neutrophils and lymphocytes—and
now we turn our attention to this important pathway.
In this study, we extend our ISAD method to simulate
leukocyte stopping via a chemokine receptor. We include
a G-protein coupled receptor (CXCR1) on the cell that,
when bound to IL-8, can initiate G-protein activation
(17,33). Further, we have embedded a G-protein signaling
network within the cell that allows us to couple chemokine
ligation to the dynamics and extent of integrin activation.
With this ISAD simulation, we recreate the transition from
rolling to firm adhesion on a timescale similar to that
observed by DiVietro et al. (18). We also predict a depen-
dence of the activation rate on IL-8 surface density consistent
with that seen experimentally. Furthermore, we explore the
effect of various rates within the signaling cascade on
the speed of signal propagation and time for leukocyte
homing. Finally we make predictions about the effect of
ligand density, flow rate, and pharmacological treatment of
G-proteins to precouple G-protein molecules with CXCR1.
The result is a comprehensive model of leukocyte firm adhe-
sion through chemokine activation that is consistent with
experiment and provides numerous testable predictions.Biophysical Journal 96(8) 2989–3004MODEL
The model used to study the transition of a neutrophil from
rolling to firm adhesion is similar to previous adhesive
dynamics models where the cell is treated as a hard sphere
with extensible cylindrical protrusions representing the
microvilli. The basic details of cell motion and stochastic
bond association and dissociation can be found in previous
work (22–24,27,32). Note that the microvilli in this model
are allowed to elastically deform, but are not allowed to enter
the tether regime (27). This provides the effect of more
robust rolling due to microvillus extension without adding
the relative complexity of the tether regime, which is unnec-
essary in this study because simulations are focused on the
signaling step of the adhesion cascade.
Adhesion module
As in other adhesive dynamics models of cell rolling, the
cells have adhesion molecules located on the tips of their
microvilli so they are able to access the uniformly adhesive
surface over which the cells flow. An illustration of the adhe-
sion molecules can be seen in Fig. 1 A. Initially, P-selectin
glycoprotein ligand-1 (PSGL-1) on the cell surface mediates
rolling by binding P-selectin. The molecular pair responsible
for firm adhesion is the integrin LFA-1 on the cell and
ICAM-1 on the reactive surface. The integrin exists in its
resting, inactive state with a low binding affinity for
ICAM-1 until it becomes activated through the signaling
cascade (7). The high affinity binding of the active LFA-1/
ICAM-1 bond is responsible for firm adhesion of the model
cell. Finally, the interaction of a third molecular pair is
included. The chemokine receptor, CXCR1 is located on
the cell and can bind to the chemokine IL-8 on the reactive
surface. It is this interaction that initiates the signaling
cascade, leading to activation of the integrins. The number
of receptors on a microvillus tip is based on published reports
(PSGL-1) (27,34–37) or is estimated from the measured total
number of receptors on the cell assuming a uniform distribu-
tion (13,33,38,39).
TABLE 1 Adhesion module parameters
Adhesion pair k0on* [mm
2/s] Dissociation rate k [s1]; f [pN]; g [A˚] l [nm] s [pN/nm] rligand [No./mm
2] rrecept [No./MV]
PSGL-1/P-selectin 1.7 k1rup ¼ 10; k02 ¼ 0.37; fb ¼ 18; F0¼ 100; f12¼ 5 70 5 60 3
Resting LFA-1/ICAM-1 0.3 k0r ¼ 4; g ¼ 1.5 24 50 50 3
Active LFA-1/ICAM-1 100 k0r;1 ¼ 0.17; g1 ¼ 2.1 k0r;2 ¼ 40; g2 ¼ 0.24 44 50 50 0
CXCR1/IL-8 0.002 k0r ¼ 0.1; g ¼ 25 18 5 220 1
*Association rates are approximated from previous work (79,80) and a large affinity increase from resting to active integrin (7). The chemokine association rate
is unknown and the value gave relatively good agreement with experimental stop times.
Chemokine-Mediated Neutrophil Adhesion 2991Each of the four possible interactions (PSGL-1/P-selectin,
resting LFA-1/ICAM-1, active LFA-1/ICAM-1, and
CXCR1/IL-8) in the adhesion module is described by its
own set of reaction rate parameters, which are given in
Table 1. All of the association rates depend on the relative
motion of the binding surfaces as described by Chang and
Hammer (40). A simple linear increase in association rate
with Peclet number (Pe) is assumed in this study, which is
a good approximation at low shear rates that we use. The
unstressed association rate is given by the following equa-
tions in the diffusion and convection limits:
k0f diff ¼ k0on
rligand
lnðb=aÞ (1)
k0f conv ¼ k0onPerligand: (2)
In these expressions, k0on is an unstressed association rate on
a per ligand density basis and is corrected for the appropriate
encounter rate by incorporation in Eq. 1 or 2. The ligand
density on the adhesive surface is given by rligand, b is the
average distance between ligand molecules, and a is the reac-
tive radius for the receptor. At low shear rates, Pe ¼ jVja/D,
where jVj is the relative velocity between the two binding
surfaces and D is the relative diffusion constant of the
binding molecules, is small. Diffusive encounter dominates
over convective encounter and Eq. 1 is used. When Pe
increases such that convection dominates, Eq. 2 is used to
determine the unstressed association rate.
As in previous models, the unstressed association rate, k0f ,
is corrected for deviation of the potential new bond from the
ideal bond length to maintain a Boltzmann distribution (41):
kf ¼ k0f
kr
k0r
exp
Ebond
kBT

: (3)
Here, kr and k
0
r are the stressed and unstressed dissociation
rates, respectively, Ebond is the potential energy of the
bond, and kBT is the thermal energy. Assuming the bond
acts as a Hookean spring in extension with spring constant
s and equilibrium length l, Ebond ¼ 1/2 s (z-l)2 is the poten-
tial energy of an extended bond of length z. However, in
compression, we assume Ebond ¼ 0 up to a cutoff point. It
is assumed that bonds experience no force up to this point,
but cannot exist compressed beyond it where the potential
energy becomes infinite. In atomic force microscopy exper-
iments, Marshall et al. (42) observed a ‘‘dead zone’’ duringwhich no force is required to extend a bound pair of mole-
cules, supporting this assumption. Each interacting pair has
unique Hookean spring parameters (Table 1) with l equal
to the sum of the molecular lengths (20,43–46) and s consis-
tent with measured values (42,43).
The dissociation rate models are different for different
bonds according to our accumulated detailed understanding
of molecular dissociation of these molecules elucidated
with molecular spectroscopy. The Bell model (47), which
describes an exponential increase in off rate with force, fits
with experimental data well. The dissociation rate, kr,
according to this model is:
kr ¼ kor exp

gf
kBT

; (4)
where g is the reactive compliance and f is the force on the
bond. The Bell model was chosen to describe the dissocia-
tion of CXCR1/IL-8, which has not been well-studied
mechanically. It has been noted, however, that it cannot
readily withstand force (18), so the reactive compliance for
this signaling bond is very large, leading to fast dissociation
at relatively low forces.
Based on single-molecule atomic force microscopy exper-
iments (48), both the inactive and active LFA-1/ICAM-1
bonds have two activation barriers for breakage. Each activa-
tion barrier has its own set of Bell model parameters, and the
overall time for dissociation (the inverse of the rate of disso-
ciation) is simply equal to the sum of the times for dissocia-
tion over each barrier. The parameters for the two barriers to
active integrin bond dissociation are from Zhang et al. (48).
For simplicity, the Bell model was chosen to describe the
resting LFA-1/ICAM-1 bond because it provides a straight-
forward model appropriate for its small role in adhesion. The
parameters for the resting integrin bond were taken to be
those for the outer barrier in the two-barrier dissociation
rate (48).
The dissociation rate for the P-selectin/PSGL-1 bond has
been shown to first decrease, then increase, with force. The
model and parameters for this catch-slip selectin bond are
given by Evans et al. (49). The bond is assumed to exist in
one of two possible states. Dissociation from state 1 is fast,
whereas that from state 2 is slower. Furthermore, state 1 is
of lower energy at zero force and is therefore highly occu-
pied at low forces. However, state 2 becomes preferentially
occupied at higher forces. This model is described by (49):Biophysical Journal 96(8) 2989–3004
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F0k1rup þ exp

f
f12
h
k02exp

f
fb
i
F0 þ exp

f
f12
 ; (5)
where F0 ¼ expðDE21=kBTÞ is the equilibrium constant
between the two states at zero force when the energy differ-
ence is DE21. The constant dissociation rate from state 1 is
k1rup, whereas, for state 2, k
0
2 is the unstressed dissociation
rate and fb is the thermal energy divided by the reactive
compliance. Finally, f12 is the force scale for the shift in equi-
librium state occupancy as a function of force on the bond.
Signaling module
As discussed, there are integrin molecules located on the
surface of the cell that can bind to their ligand ICAM-1 on
the reactive surface. At the beginning of the simulations,
LFA-1 exists in its resting state, but, through signaling, it
can be activated to the high-affinity state responsible for
firm adhesion of the cell. The model for signaling is
described in this study and depicted in Fig. 1 B.
Although there has been a great deal of research to deter-
mine the players in leukocyte activation, the signaling
cascade is not completely understood (50), especially for
the initial activation leading to firm adhesion. We have there-
fore rendered the G-protein signaling network into a simple
yet reasonable pathway. It is known that chemokines bind to
G-protein coupled receptors (GPCRs) on the cell, activating
the G-protein (13), so our model begins there.
The chemokine IL-8 on the reactive surface can bind to
CXCR1, the GPCR on the cell surface, located on the micro-
villus tips in this model. At the same time, G-proteins inside
the cell can diffuse and bind to the intracellular portion of
CXCR1. When IL-8 is bound to the extracellular portion,
CXCR1 is activated and can then in turn activate a coupled
G-protein. On activation, the G-protein splits into two active
subunits, Ga and Gbg. Each of the subunits can diffuse in the
membrane. It is assumed that the Gbg subunit acts to propa-
gate the signal in this case (51–53). Because the remainder of
the signaling process is likely complicated and not defini-
tively known for granulocytes, we simplify it by saying
that a small cytoplasmic molecule called the Effector acts
as the intermediate between G-protein activation and LFA-1
activation. Recent evidence in lymphocytes suggests the key
effector is Rap1 (54,55), but a different molecule may play
the role in granulocytes.
The Effector can receive the Gbg signal by diffusing into
contact, binding, and then becoming active. The Effector
can then diffuse to a resting LFA-1 molecule and bind to
its intracellular portion, thereby affecting a conformational
change that activates the integrin. When the Effector dissoci-
ates from an active LFA-1 molecule, the integrin may relax
back to its resting state. Meanwhile, the free and active Ga
subunit may become inactive, allowing it to rebind with
the Gbg subunit, reforming the inactive G-protein. This is
similar to how Rap1 works in lymphocyte systems.Biophysical Journal 96(8) 2989–3004This signaling process can occur independently in each
microvillus and is assumed to take place on a one-dimensional
lattice, with 1000 rungs along the length of the 0.3 mm-long
microvillus. Each microvillus contains 5 G-proteins and
5 Effectors, and these mobile elements are randomly assigned
a starting position on the lattice. Other signaling elements that
are also involved in adhesion are in a fixed position at the
bottom of the lattice, representing the microvillus tip. Essen-
tially, we are looking at local integrin activation rather than
global activation due to the restriction to independent micro-
villi.We believe this is likelywhat happens at short times after
exposure to endothelium-expressed chemokines (50), and
future versions of this integrated model may be created that
allow longer length and timescale signal transduction.
The diffusion and reaction steps in the signaling module
occur at every time step, Dt ¼ 107 s, within the ISAD
algorithm. The signaling module begins by allowing all
mobile elements to diffuse by randomly choosing a direction
for their motion. The hop size, Dx, for a particular element
along the lattice is determined by the diffusion constant, D,
of that element and the time step of the simulation as follows:
D ¼ ðDxÞ
2
2Dt
: (6)
Because the G-protein and its subunits are assumed to be
membrane-bound, their hop size of one rung is smaller than the
10-rung hop size of the cytoplasmic Effector molecule. These
hopsizesgivediffusioncoefficientsof0.45and45mm2/s.
After the diffusion step, each signaling element is allowed
the possibility to react with nearby elements. This possibility
is calculated from random number sampling of reaction
probabilities. If the signaling element is already bound to
another, the possible reactions include i), dissociation, and
ii), catalytic spin flip (25), where the presence of one active
element increases the rate at which the inactive element
becomes active. If the element is not bound, it may i), asso-
ciate with an unbound element that is within reactive
distance (10 rungs), or ii), undergo an auto spin flip, where
an active molecule switches back to its inactive state.
The rate, k, of each possible reaction, i, is given in Table 2
for the base case. Association rates are the intrinsic reaction
rate for a molecular pair that has already encountered by
diffusion, and are fast because reactions are assumed to be
diffusion limited (56). Other rates are based on previous
signaling models (57,58). Unknown Effector rates are
assumed to be of the magnitude of similar reactions and
will be explored. The probability, P, that a reaction will
occur during a given time step is:
Pi ¼ 1 expðkiDtÞ: (7)
The probability that a particular element will have no
reaction is simply the product of the probabilities that
each possible reaction will not occur,
Q
ið1 PiÞ. Therefore,
the probability that some reaction will occur for a particular
element is:
TABLE 2 Signaling module base case reaction rates
Reaction* Rates:y Association Dissociation
(Auto)
Spin flip
CþG/
1
)
10
CG 1  104 0.03 —
C þG/2)
11
CG 1  106 0.01 —
CG /
16
C þGa þGbg — — 5.0
Gbgþ E/4)
12
GbgE 5  105 0.1 —
GbgE /
17
GbgE — — 10.0
GbgE /
13
)
5
Gbgþ E 1  105 0.1 —
Iþ E /8 IE 1  106 — —
IE /
14
)
6
I þ E 1  106 0.1 —
LIþ E /9 LIE 1  106 — —
LIE /
15
)
7
LI þ E 1  106 0.1 —
I /
20
I — — 1.0
LI /
21
LI — — 0.01
E /
19
E — — 1.0
Ga /
18
Ga — — 0.1
GaþGbg /3 G 1  106 — —
*Signaling elements are abbreviated as follows: C, CXCR1; G, G-protein;
Ga, Ga; Gbg, Gbg; E, Effector; I, LFA-1; LI, ligand-bound LFA-1. When
two symbols are written together, they are bound. A star signifies an active
element as opposed to the inactive form.
yAll reaction rates are given in units of s1. Association rates are the intrinsic
reaction rate of a molecular pair that has already encountered by diffusion.
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where ktot ¼
P
i
ki is the sum of the rates of all possible reac-
tions for a particular element. If a reaction indeed happens
according to Monte Carlo sampling, it is assumed that
only one reaction occurs during the time step. The reaction
that occurs is chosen randomly based on the individual reaction
rates compared to the total, with faster reactions more likely to
occur.
Aside from obvious differences in the identities of the
signaling components, our implementation of the signaling
algorithm differs somewhat from that used in previous
work from our lab (25). The basic idea of stochastic diffusion
of signaling elements and reaction on collision is the same.
However, instead of calculating probabilities based on
activation energies as before (25), we now use reaction rates
so that the signaling and adhesion modules take similar
approaches. Kruk et al. (59) used an algorithm similar to
this signaling algorithm in a study of the dynamics of central
synapses. In addition, this model includes deformable
microvilli, which permit smaller, more realistic numbers of
adhesion molecules on the cell surface while still providing
significant adhesion. Also, adhesion molecules in this model
have different bond lengths and spring constants. Theincrease in length experienced by an activating LFA-1 mole-
cule is included as well.
Computation
Simulationswere programmed inCþþ usingMicrosoftVisual
Cþþ 6.0 and run on a Dell Precision Workstation with 3.06
GHz Intel Xeon processors. Simulations began with the cell
in binding proximity to the adhesive surface and exposed to
a shear flow. Adhesion and signaling molecules were immedi-
ately allowed to interact according to the algorithm described
above. Cell center and microvillus positions, along with
bonding data, were recorded every 0.1 s. Results were visual-
ized with MATLAB 6.5 (The MathWorks, Natick, MA).
RESULTS
The ISAD model was used to simulate a neutrophil as it rolls
and then stops on a surface displaying a set of molecules at an
inflammatory site at a shear rate of 100 s1, unless indicated
otherwise. In the results that follow, a cell was considered
stopped and the simulation was ended when it progressed
less than half of a cell diameter in 10 s. At each set of param-
eters examined, the simulation was run six to nine times and
the results averaged. Error bars represent the standard error.Basic results
First, we simulate an experiment in which neutrophils are
convected over a surface coated in adhesion molecules and
chemokines, and ultimately roll and stop. As in the experi-
ments by DiVietro et al. (18), we use P-selectin, ICAM-1,
and IL-8 as the surface molecules to provide rolling, firm
binding, and signal initiation, respectively. We found that
the model cells indeed rolled and came to a stop, as seen
in the sample trajectories in Fig. 2 A for an IL-8 density
of 220 sites/mm2, which corresponds to one of the densities
used by DiVietro et al. (18). In this simulation, as in the
experiment (18), the densities of P-selectin and ICAM-1
were 60 and 50 sites/mm2, respectively. Most of the simu-
lated trajectories have some longer pauses as the cell
approaches firm adhesion due to the emergence of a small
number of active integrin bonds. This slowing before stop-
ping was also noted in experiments (18).
For the cell whose trajectory is highlighted in gray
(Fig. 2 A), several quantities calculated during the simulation
are presented in Fig. 2,B–I, as a function of time. The velocity
gradually decreases as the cell becomes active and comes to
a stop (Fig. 2 B). The longer pauses correspond to times
when microvilli with active integrins are bound (Fig. 2, C
and D). The numbers of chemokine, selectin, and resting
LFA-1 bonds fluctuate through the simulation, but show
less fluctuation once the cell stops and the microvilli in the
contact area do not change (Fig. 2, E–G). We observed
a gradual increase in the number of active integrin molecules
on the cell (Fig. 2 C). The first integrin was activated afterBiophysical Journal 96(8) 2989–3004
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FIGURE 2 Example results for
activation leading to firm adhesion.
(A) Several trajectories are shown de-
picting the slowing and stopping of
simulated cells as they become active.
All trajectories are for an IL-8 density
of 220 sites/mm2 and base case parame-
ters, but with different random number
seeds. The trajectory of a rolling cell
that is not allowed to become active is
indicated by a gray dashed line for
comparison. Several quantities calcu-
lated during the simulation are shown
in (B–I) for the cell with the gray trajec-
tory. (B) Velocity as a function of time.
Both the backward 0.1-s average
velocity and centered 1-s average
velocity are shown. The cell slows and
has longer pauses as it rolls. (C) Number
of microvilli with active integrins. The
total number of active microvilli gradu-
ally increases as the cell accumulates
signal, but the number of active
microvilli bound at the time of firm
adhesion is small. (D) Number of active
integrins on the cell, available to bind in
the contact area, and bound. About 2 s
go by before any LFA-1 becomes
active, and then the total gradually
increases. A majority of those active
integrins near enough to bind to the
surface are bound. (E) Number of
chemokine bonds. This number fluctu-
ates but remains small. (F) Number of
selectin bonds. (G) Number of resting
LFA-1 bonds. (H) Number of active
Gbg in the cell. G-proteins become
active quickly and the number gradually
increases. There are some decreases
because Ga can deactivate and recom-
bine with Gbg. (I) Number of active
Effector molecules in the cell.
2994 Caputo and Hammerabout 2 s of rolling, during which the initial steps in the
signaling cascade occurred. We refer to this as the ‘‘time to
first activation’’ and this time varies from cell to cell due
to the stochastic nature of the simulation and according to
parameter values. With the parameter values used here, the
LFA-1 that becomes active is not immediately available to
bind because the microvillus may rotate out of the contact
zone before activation occurs. However, once the active
LFA-1 molecules reenter the contact zone, they rapidly
bind. As mentioned, the signaling cascade is active before
the first integrin becomes active. The small number of chemo-
kine bonds is sufficient to quickly initiate signal transduction,
as indicated by active Gbg and Effector molecules at early
time points (Fig. 2, H and I). The quantities of both of these
intracellular signaling molecules increase as the cell rolls
and accumulates IL-8 signal, becoming active.Biophysical Journal 96(8) 2989–3004Effect of IL-8 density
Prompted by the study by DiVietro et al. (18), we looked at
the effect of varying IL-8 density on the transition to firm
adhesion. Fig. 3 A shows good agreement between the
distances rolled before stopping in simulations and in exper-
iments, with increasing distance to stop as the IL-8 density
decreases (18). In Fig. 3 B, both the time and distance rolled
in the simulations before stopping are presented. At very
high IL-8 densities, the time to stop approaches a minimum
because the time the chemokine signal takes to propagate
through the cell to activate the integrins becomes rate-
limiting. If no IL-8 were present, cells would continue to
roll and never stop as no signal would be initiated. Because
cells have an average velocity that does not significantly vary
with IL-8 density, the distance the cells roll before stopping
AB
FIGURE 3 Effect of IL-8 density on time and distance rolled before firm
adhesion. (A) Distance rolled before firm adhesion at various IL-8 densities.
For comparison, distances from DiVietro et al. (18) are shown with the simu-
lation results. (B) Time and distance to stop in simulations at the indicated
IL-8 densities. Cells flowing over a surface with a higher chemokine density
achieve firm adhesion more quickly than those exposed to lower chemokine
densities. The time and distance to stop approach a minimum at the highest
IL-8 densities tested.
A
B
FIGURE 4 Number of active integrins present at the point of firm binding
for various chemokine densities. (A) Average number of active LFA-1
molecules on the entire cell, within the contact area, and bound to their ligand
ICAM-1 at the end of the simulation for each IL-8 density. The total number
of active integrins on the cell clearly decreases with IL-8 density. But, the
number with the potential to bind and the number bound at the stoppage point
remain relatively constant. (B) Number of active integrins bound when the
cell is firmly adherent as a function of time to stop for each run. Runs at
the same IL-8 density are given by the same symbol. No cell stops with fewer
than 4 active integrin molecules bound, but cells exposed to higher IL-8
densities are more likely to stop with more active integrins bound.
Chemokine-Mediated Neutrophil Adhesion 2995corresponds to the time they take to stop. However, as noted
in Fig. 2, the cells roll more quickly at first and slow as
integrin molecules become active before coming to a stop.
Thus, velocity decreases as cells roll on an IL-8 substrate.
The number of active LFA-1 molecules present during
rolling and activation is explored in Fig. 4 A. At the time
of arrest, there are more active integrins on the whole cell
when the cell is exposed to a surface with a high IL-8
density. Interestingly, the number of active LFA-1 molecules
that are in the contact area and the number that are bound
to ICAM-1 when the cell comes to a stop are relatively
constant for all chemokine densities. We hypothesize that
firm arrest only requires a small number of ligated active
LFA-1, as determined by the mechanics of adhesion, even
though there could be widespread LFA-1 activation over
the cell. In Fig. 4 B, we illustrate the number of active
LFA-1 engaged and the corresponding time to stop. Appar-ently, there is a minimum number of active LFA-1 bonds
required for a cell to stop. This is dictated by the mechanics
of adhesion. At each IL-8 density tested, cells will stop once
the minimum number of active integrin bonds is surpassed,
but cells exposed to higher densities of chemokine are
more likely to come to arrest with a larger number of active
integrin bonds. At high IL-8 densities, integrins are rapidly
activated. The number of active integrins (Fig. 4 A) is high
and the number of ligated active integrins is greater than
the minimum required for arrest. This is because the integrin
activation rate exceeds the adhesion rate, leading to more
integrin activation than required for adhesion. At low IL-8
densities, cells ultimately come to a stop with the minimum
number of active LFA-1 bonds needed for adhesion,Biophysical Journal 96(8) 2989–3004
AB
FIGURE 5 Integrals over rolling time and the characteristic activation
time. (A) Average value of the number of chemokine bonds and number
of active integrin molecules on the cell integrated over the rolling time for
each IL-8 density. The chemokine integral is smaller for smaller values of
the IL-8 density whereas the active integrin integral shows a minimum.
(B) The average time to the first integrin activation as a function of the
average time to stop plotted for each IL-8 density. The average time to
stop correlates well with this measure of a characteristic activation time.
2996 Caputo and Hammeralthough it takes a longer time for these adhesion molecules
to accumulate and for the cell to stop (Fig. 4 B).
Both the number of active LFA-1 molecules on the cell and
the amount of time an activating cell is exposed to the
adhesive surface contribute to the time it takes to stop, so it
is interesting to examine the integrals of activity over time.
Fig. 5A reports the values of the integral of the active integrins
on the cell and the integral of chemokine bonds over the
rolling time of the cells. The integral of chemokine bonds
clearly decreases with decreasing IL-8 density. At the lower
chemokine densities, there is less IL-8 available to bind. As
the chemokine density decreases, the cell rolls further, but
because chemokine density is lower, the integral of chemo-
kine bonds goes down. The integral of active LFA-1 over
the rolling time, surprisingly, goes through a minimum with
IL-8 density (Fig. 5 A). A possible explanation is that at
high IL-8 densities, the integral of active LFA-1 is high
because there is an overproduction of active LFA-1 beyondBiophysical Journal 96(8) 2989–3004that needed for arrest. These molecules can accumulate
because it takes some time for the cell to arrest even at
a high level of activation. At the lowest chemokine densities,
there is a period of time where the number of active integrin
molecules in the contact zone is too low and the cell cannot
bind firmly, but the total number of active integrins continues
to accumulate. The net result is that there is a minimum in the
integral of active LFA-1 at an intermediate IL-8 density.
A further detailedmathematical explanation of this possibility
is presented in Appendix A.
We have explored various metrics to understand the
timescale of cell arrest, including the total number of active
integrins on the cell and the integral of the number of chemo-
kine bonds over rolling time. Theses quantities did not
correlate with the time to stop. Instead, we find that the best
indicator of the time it takes a cell to stop is the time for the
first integrin molecule to become active. The correlation can
be seen in Fig. 5 B. It was previously discussed that the time
to stop approaches a minimum as the chemokine density
increases (Fig. 3 B). This idea is mirrored in the time to first
integrin activation. Even though IL-8 binding may initiate
a signal very quickly when the IL-8 density is high, the signal
still must propagate through the signal transduction network.
The speed of this propagation is limited by the components of
the cascade. Thus there is a lower limit for the time for the first
integrin to be activated. At low chemokine density, the time
for the first integrin to be activated suggests the rate at which
individual microvilli will receive a sufficient signal. Because
the number of activated microvilli is low, each active micro-
villus contributes essentially the same to the probability of
firm adhesion, thus the linear correlation of time to first integ-
rin activation and time to stop at low IL-8 densities.Effect of signaling network
Next we explore the effects of parameters within the
signaling cascade, keeping the chemokine density constant.
We focus on parameters involving the Effector molecule
because it represents an ill-defined part of the pathway.
Active Effector-Gbg dissociation
After an active Gbg subunit binds to an Effector molecule
and activates it, the active Effector must dissociate and
diffuse away to bind to and activate an integrin molecule.
Thus, the dissociation rate of an active Effector molecule
and a Gbg subunit (rate 13 in Table 2) affects how quickly
the initial signal can lead to integrin activation and adhesion.
As expected, when active Effector dissociates more
slowly from the Gbg subunit, the cell takes longer to firmly
adhere, as shown in Fig. 6 A. At very fast dissociation rates,
stop times approach a minimum as other steps in the
signaling cascade limit the speed of activation. Also, the
time to activate the first integrin again correlates well with
the time to firm adhesion. The number of active integrin
molecules available to bind and the number bound at the
BA
FIGURE 6 Changes in the activeEffector-Gbg dissociation rate. (A) Time to
stop and time to first activation. The average time to stop for each value of the
active Effector-Gbg dissociation rate is plotted as a bar graph. The average time
to the first activation as a function of the average time to stop is also included,
with each colored symbol corresponding to the dissociation rate value of the
same color. The faster integrin activation afforded by a faster dissociation
rate results in a shorter time to stop. The time to the first active integrin corre-
lateswellwith the time to stop. (B)Ahistogramof the number of active integrin
molecules permicrovillus at the stoppage point fordifferent values of the disso-
ciation rate.At the lowest dissociation rate, integrin activation is slow and there
are many microvilli with a small number of active integrins. At faster dissoci-
ation rates and faster activation, the most probable and average active integrin
density per microvillus increases. The total numbers of active microvilli repre-
sented are 18.5, 12.7, and 8.3 in the three cases, respectively.
A
B
FIGURE 7 Time to stop and time to first activation for different signaling
rates. (A) Changes in the Effector activation rate. When the Effector activa-
tion rate is small, integrin activation is slower, which correlates with the time
to stop. (B) Changes in active Effector-LFA-1 dissociation rate. Neither the
time to stop nor the time to first activation significantly vary with large
changes in the dissociation rate, indicating that activation propagation by
a single active Effector is not a crucial process in this model.
Chemokine-Mediated Neutrophil Adhesion 2997point of stopping are relatively constant for all active
Effector-Gbg dissociation rates (data not shown). Unlike
when the IL-8 density was varied, the total amount of acti-
vated integrin at the point of arrest is the same at all dissoci-
ation rates. When varying the Effector-Gbg dissociation rate,
the input (IL-8) is the same, but the transduction to the integ-
rin is different. Thus, it is the rate of LFA-1 activation in each
microvillus that differs, resulting in a distribution of the level
of activation per microvillus that depends on the intracellular
signaling rate. The distributions at the point of arrest for
various dissociation rates are shown in Fig. 6 B. At lower
dissociation rates, the intracellular signaling is slower andtherefore there are more microvilli that have low numbers
of active integrin molecules on them. Because adhesion
probability increases greatly when adhesion molecules are
clustered, the slower-activating cells must roll longer before
they have enough microvilli with a high enough level of
active integrin to achieve firm adhesion. Because of this
effect, the total number of active LFA-1 molecules on cells
at the point of arrest is relatively constant, with the lower
intracellular signaling rates having more active microvilli,
but with fewer active LFA-1 per microvillus on average.
At higher active Effector-Gbg dissociation rates, the distribu-
tion of active integrins per microvillus increases to an
average value of 2.84  0.2 (compared to 2.60  0.12 at
the base case). Correspondingly, cells stop slightly faster
than at the base case dissociation rate (Fig. 6 A).
Effector activation
We also examined the effects of varying the rate at which an
Effector molecule becomes active when bound to an active
Gbg molecule (rate 17 in Table 2), as seen in Fig. 7 A.Biophysical Journal 96(8) 2989–3004
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FIGURE 8 Time to stop and time to first activation with and without
G–protein precoupling to the chemokine receptor. For both the base case
parameters and a set of parameters that allowed faster intracellular signaling,
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quantities are also shown when the simulation was initiated with some
G-protein and CXCR1 precoupled. There is no notable difference for the
base case parameters, but with faster intracellular signaling, precoupling
further decreased the time to the first activation.
2998 Caputo and HammerWhen this rate is small, the intracellular signaling process is
slow and leads to longer periods of rolling before firm adhe-
sion, as anticipated. Again, slower steps in the signaling
cascade limit the overall speed of integrin activation, result-
ing in a lower limit to the time to firm adhesion for fast
Effector activation rates.
Active Effector-active LFA-1 dissociation
Additionally, we explored the rate of active Effector dissoci-
ation from active integrin (rates 14 and 15 in Table 2) in
Fig. 7 B. Once an Effector molecule binds to and activates
an integrin, it can dissociate from the integrin and go on to
activate another integrin. However, an active integrin
without a bound Effector may deactivate. The net effect is
that the rate of active Effector dissociation from active
LFA-1 did not have a significant effect on the time to stop.
Even when active Effector was not allowed to dissociate
from an active integrin, the time to stop did not increase
because that integrin remained active and other Effector
molecules in the microvillus were available to pass along
the signal. When the dissociation rate was fast, the number
of active integrins on a microvillus rapidly increased, but
the time to stop was still limited by the contact time between
the active microvilli and the adhesive surface. Although
some deactivation did occur, it was not integrin deactivation
due to Effector dissociation that limited the time to stop,
because setting the integrin deactivation rate to zero did
not change the results (data not shown).
G-protein precoupling
With this model, we were able to examine potential benefits
of G-protein precoupling with the chemokine receptor so it isBiophysical Journal 96(8) 2989–3004ready to be activated as soon as chemokine binds. To
study this, we initialized the simulations with a number of
G-protein molecules already bound to CXCR1 at the micro-
villus tip. The number of precoupled G-proteins in a given
microvillus was chosen randomly from a uniform distribu-
tion from zero to the maximum possible. Our findings are
presented in Fig. 8. We found that G-protein precoupling
does not speed up cell arrest, most likely because other steps
in the cascade are limiting.
Effect of external parameters
Finally, we investigated the effect that easily adjustable
experimental parameters could have on the dynamics of
firm adhesion at a constant IL-8 density of 220 sites/mm2.
These parameters were P-selectin density, ICAM-1 density,
and shear rate. Fig. 9 A shows that, as long as there is
some selectin present, the time to stop does not significantly
change as selectin density increases. However, the distance
rolled until firm adhesion decreases, corresponding to the
rolling velocity decreasing with increasing selectin density.
Because a similar number of active integrin bonds is required
for arrest under all selectin densities tested (Fig. 9 B), cells
must roll approximately the same time to achieve this level
of activation before stopping. The total number of active
integrins does increase with increasing selectin density.
At lower selectin densities when cells are rolling more
quickly, each chemokine bond will not persist as long.
This decreases the opportunity for an active CXCR1 to
activate a G-protein. Therefore, as seen in Fig. 9 C, fewer
microvilli are activated for lower selectin densities, but
each activated microvillus displays the same level of integrin
activation, which ultimately allows firm adhesion with
a small number of fully active microvilli. In the absence of
selectin, the rolling velocity is significantly larger than
when some selectin is present (38 mm/s vs. 16–5.2 mm/s),
with only integrin interactions to slow the cell (unactivated
b2-integrins support rolling on ICAM-1). At this large
velocity, microvilli are activated slowly, leading to a longer
time before firm adhesion (Fig. 9 A).
Interestingly, increasing the ICAM-1 density does not
affect the time to arrest, because a similar number of active
integrins are bound at the point of firm adhesion under all
ICAM-1 densities (Fig. 10 A). The number of active LFA-1
molecules on the cell is limiting in this case. The distance to
stop, however, decreases with increasing ICAM-1 density,
because of differences in rolling velocity. With higher
ICAM-1 densities, resting LFA-1 bonds contribute to slow
the rolling velocity, as illustrated by the 1-s average velocity
as a function of time in Fig. 10 B, in which the cells roll
slowly from the beginning of the simulation, before integrins
are activated.
We also tested the effect of shear rate on the transition
from rolling to firm adhesion. As seen in Fig. 11, cells roll
for longer times and distances before stopping when exposed
to higher shear rates. At higher shear rates, more active LFA-1
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FIGURE 9 Effect of P–selectin density on the transition to firm adhesion.
(A) Time and distance rolled before stopping on various P-selectin densities.
As long as selectin is present, time to stop does not vary, however the
distance to stop depends on the rolling velocity at the various selectin
densities. (B) Average number of active LFA-1 molecules per cell at the
point of firm adhesion. The total number of active LFA-1 molecules on
the entire cell surface increases somewhat with selectin density whereas
the number available to bind and bound on stopping remains relatively
constant. (C) Average number of active microvilli at per cell at the point
of firm adhesion. The total number of microvilli with any active integrins
slightly increases as the selectin densities increases. However, the number
of active microvilli bound on stopping does not significantly change.
Chemokine-Mediated Neutrophil Adhesion 2999bonds are required for the cell to stop, and it takes longer to
reach that level of activation. Additionally, when cells are
moving quickly at high shear rates, chemokine bonds do
not last as long, so there is less time for the signal to be
activated intracellularly where it can propagate and the rate
of activation is slightly slower. This effect is small; the
requirement of a larger number of active integrin bonds for
cells to stop at higher shear rates is the main reason for the
increase in the time to stop.DISCUSSION
There are several mechanisms by which leukocytes may
become activated to firmly adhere after a period of rolling
at sites of inflammation. Some experiments suggest that
selectin ligation during rolling serves also to signal integrin
activation in the cell (60–62). Our lab previously recreated
the transition from rolling to firm adhesion in an ISADmodel
by incorporating a MAPK signaling cascade into the cell.
The activating signal was initiated by PSGL-1 on the cell
surface binding to E-selectin (25,32). Another commonly
shown method of cell activation is through exposure to
inflammatory chemokines that bind to GPCRs on the cell
(14,17–19,63). On release from endothelial cells, chemokine
molecules have been shown to bind to glycosaminoglycans
on the endothelial surface for juxtacrine presentation
to rolling neutrophils (64,65). In this study, we focused
on chemokine-mediated neutrophil activation through a
G-protein signaling cascade.
We have extended previous Adhesive Dynamics models
of cell rolling via selectin bonds to include the transition to
firm adhesion. To simulate the transition from rolling to
firm adhesion, we incorporated a signaling cascade that takes
an initial extracellular chemokine signal and transforms it
intracellularly through G-proteins to activate high-affinity
integrin molecules on the cell surface. This ISAD model
successfully recreated the transition from rolling to firm
adhesion and was used to explore the effects of components
of the signaling network on the dynamics of adhesion, as
well as the effect of easily adjustable parameters on the
time to become firmly bound.
Our simulations showed that, as cells rolled, they accumu-
lated signal that resulted in a gradual increase in the number
of active LFA-1 molecules on the cell. With the presence of
high-affinity integrin bonds, cells began to exhibit longer
pauses while rolling, followed by firm adhesion. When
exposed to larger densities of chemokine on the adhesive
surface, cells stopped more quickly, an observation also
made in vitro by DiVietro et al. (18). Although larger chemo-
kine densities resulted in more active integrins on the cell
surface at the time of firm binding, the number of activeEach active microvillus is activated to the same degree, on average, as
indicated by a constant number of active LFA-1 molecules per active
microvillus.
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AB
FIGURE 10 Effect of ICAM-1 density on the transition to firm adhesion.
(A) Average distance to stop and number of active LFA-1 molecules per cell
at various ICAM-1 densities. The distance rolled before firm adhesion
decreases with increasing ICAM-1 densities because the rolling velocity
decreases. The average number of active LFA-1 molecules available to
bind and bound when the cell becomes firmly adherent do not significantly
vary, suggesting that the number of active LFA-1 molecules on the cell is
limiting for firm adhesion. (B) Average 1-s average velocity as a function
of time for all cells at each ICAM-1 density tested. The average velocity
over the previous 1 s was found for each cell as a function of time and
the results were averaged for each set of conditions. At higher ICAM-1
densities, the cells roll more slowly starting at the beginning of the simula-
tion, indicating that resting LFA-1 interactions are slowing the cells. These
cells roll shorter distances, yet stop in about the same amount of time as cells
exposed to lower ICAM-1 densities.
FIGURE 11 Effect of shear rate on the transition to firm adhesion. The
time and distance rolled before stopping and the number of active LFA-1
bonds during firm adhesion are plotted for various shear rates. All quantities
increase with shear rate. More active integrin bonds are required for stopping
at the higher shear rates because of the larger force of flow, and it takes more
time to reach the required level of activation. The time to stop increases more
rapidly than the number of active integrins required, indicating that the rate
of activation decreases slightly as shear rate increases due to the limited
persistence time of the chemokine bonds during the faster rolling.
3000 Caputo and Hammerintegrin bonds at the point of firm adhesion was relatively
constant. Our results are consistent with the experimental
observations of DiVietro et al. (18); furthermore, we predict
that densities of IL-8 higher than in the experiments would
not change the time to stop, but lower densities than they
used would further increase the time to stop (Fig. 3). We
assessed the effect of external parameters on the transition
to firm adhesion as well. Neither selectin density nor
ICAM-1 density dramatically changed the rolling timeBiophysical Journal 96(8) 2989–3004before firm adhesion, although they did affect the distance
rolled because they altered the rolling velocity. Because
the number of active LFA-1 bonds required for firm adhesion
increases as shear rate increases, the time before firm
adhesion also increases. This time is required for the cell
to accumulate more active LFA-1 molecules.
We noted that the timescale to activate one integrin mole-
cule correlated with the time it took the cells to ultimately
stop. Changing reaction rates within the signaling cascade
also affected the time to stop in accord with the resulting time-
scale for integrin activation. Furthermore, these simulations
that varied the speed of intracellular signaling suggested
a role for integrin clustering in firm adhesion. With slower
active Effector dissociation from the Gbg subunit or a slower
Effector activation rate, intracellular signaling is conse-
quently slower and cells take longer to become adherent.
However, changes in the rate of active Effector dissociation
from active LFA-1 did not have a significant effect on the
time to stop. We also found that G-protein precoupling with
CXCR1 could contribute to faster activation only if the
remainder of the signaling cascade was fast. This indicates
that scaffolding many of the components of the signaling
cascade near the site of initial activation could speed up
integrin activation and the onset of firm adhesion.
We also considered the effects of two pharmacological
treatments of G-protein networks that are typically carried
out. One is to use a toxin, such as pertussis toxin; this would
have destroyed the G-protein activity, and there would
have been no adhesion at all. The second is to use a nonhy-
drolyzable GTP, such as GTPgS. GTPgS would prevent
Chemokine-Mediated Neutrophil Adhesion 3001Ga deactivation and hence the reassembly of the G-protein,
which prevents deactivation of Gbg. We carried out simula-
tions in which the Ga deactivation rate was zero to model the
effect of GTPgS (data not shown). They indicated little
effect on the time to stop, suggesting that the Gbg deactiva-
tion rate, which includes Ga deactivation and subsequent
recombination with Gbg, is already slow in this model.
In the base case simulations, a rolling cell generally
stopped on the order of tens of seconds, with integrins
becoming active on the order of a second. When parameter
changes were made such that the integrins on a chemokine-
activated microvillus became active very quickly, this
increase in activation was not manifested in the time to
stop. Because of the morphological simplifications of this
model, it is highly unlikely for a microvillus to become
active and then firmly adhere during the same visit to the
contact area. Instead, adhesion of active integrins occurs
on reentry into the contact area after a full cell rotation.
This prevented some potential benefits of fast activation
from being observed. Still, it is possible that fast activation
can indeed lead to faster firm binding, which some changes
in the model could reveal. If activation was not as local as to
be restricted to the microvillus in which it was initiated,
integrins could be activated further from a chemokine
binding site. Activation occurring at the leading edge of
the contact zone, then, could make more rapid firm adhesion
possible.
With a hard sphere model for the cell, only molecules
located on the microvillus tips can reach and bind to the
surface. Therefore, we model only those integrins that might
be located on the microvillus tips assuming a uniform distri-
bution of integrins on the cell surface. We showed in this and
previous work that clustering on the microvillus tips can
contribute to stronger adhesion (27). However, it is possible
that integrin molecules tend to be on the cell body rather than
the microvilli (66,67), with deformability of the cell surface
and membrane unwrinkling allowing these molecules to
contact the vessel wall (68,69). Simulation results would
change if the integrin molecules were not located on the
microvillus tips, but this assumption may approximate other
features of the cell adhesion process. For example, ICAM-1
molecules are preferentially located on endothelial microvilli
(13), which could facilitate adhesion to endothelial cells
much like integrin localization to neutrophil microvilli. As
further validation, it has been proposed that besides an
increase in integrin affinity for ICAM-1, the integrins may
cluster on activation (70–74). By localizing integrins to the
neutrophil microvilli in this model, we are effectively clus-
tering them, which contributes to the achievement of firm
adhesion. Further, one can include other b2-integrins, such
as Mac-1, although we suspect these molecules are upregu-
lated too slowly to affect the initial arrest of the leukocyte.
We previously modeled cell activation via the PSGL-1/
E-selectin-mediated MAPK pathway using a similar method
(25). Although an in-depth comparison between this modeland the previous model (25) is not possible due to the
increased detail in the current work, we can compare some
trends. Both models showed a gradual increase in the
number of active integrins on the cell as the cell rolls.
Furthermore, increasing the rate of activation resulted in
a shorter rolling time before stopping in both models. In
addition, the time to stop approached a minimum for fast
activation rates. Increasing E-selectin density, which
provided the signal when bound to PSGL-1 in the previous
model, resulted in a faster time to arrest (25). Similarly,
increasing the IL-8 signal in this model allowed the cell to
stop more quickly (Fig. 3). Changes in ICAM-1 density,
however, gave different results. In the previous model
(25), increasing the ICAM-1 density led to a faster time to
arrest, whereas ICAM-1 density affected the distance to
stop, but did not significantly affect the time to stop in this
model (Fig. 10). The difference may be due to the number
of integrin molecules on each microvillus in the models. In
this study, the number of LFA-1 on the cell is small and
likely limiting, but it is significantly larger in the previous
work (25). In a neutrophil, it is possible that both the selec-
tin-mediated MAPK pathway and the chemokine-mediated
G-protein pathway are acting simultaneously; thus syner-
gism between two or more pathways could be incorporated
into the model. There is potential to use a model like this
to examine alternative activation pathways, perhaps to
predict which is dominant in a given situation. As more
details regarding activation networks within neutrophils
emerge, they can be easily incorporated in an ISAD model.
A basic difference between the two models, however, is
how adhesion and signaling are coupled. In the MAPK
simulations (25), the adhesion molecule supporting rolling
also generated a signal. In this study, the chemokine receptor
generates a signal with limited adhesive function, and an addi-
tional molecule (PSGL-1) supports rolling adhesion. In both
models, signaling results in integrin conformational change.
However, neither model incorporates a force-dependent
change in the adhesive function or signal sensitivity of the
adhesion molecules themselves. This may be an oversimplifi-
cation, because Alon and Ley (75) have speculated that adhe-
sive force can ‘‘prime’’ an adhesion molecule and make it
more susceptible to activation. Because conformational
changes in adhesion molecules are downstream of signaling
and because signaling and rolling adhesion are uncoupled in
both of our models, we do not believe there is any funda-
mental difference in how the two systems activate integrin-
mediated adhesion. Rather, the differences are restricted
only to differences in the topology of the signaling network
and the concentration of its constituents.
It should also be noted that an important future use of
these simulations is to examine lymphocyte activation.
Lymphocytes use multiple chemokine receptors and their
ligands to identify sites of homing. The combination of
chemokine identity and density lead to integrated signals
that can activate integrins, stimulate adhesion, and dictateBiophysical Journal 96(8) 2989–3004
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FIGURE 12 Theoretical active integrin integrals as a function of activa-
tion rate. The integral in Eq. A2 is plotted as a function of activation rate
for various forms of the minimum adhesion time, t1. When t1 ¼ 0 s, kad is
a linear function of r and the integral is constant as mentioned in the text.
When t1 is nonzero as in Eq. A5, the integral is no longer constant.
Introducing a tmin generates a minimum in the integral. For this simple
demonstration, kon ¼ 1 mm2/s and r0 ¼ 1 site/mm2.
3002 Caputo and Hammerhoming patterns (75). We will address this integration in
future work.APPENDIX A
Analytic Model For Stopping
As noted in Fig. 5 A, the integral of active LFA-1 over rolling time
is relatively constant, but has a slight minimum as IL-8 density varies.
The idea that both the number of active integrins and contact time with
the adhesive surface contribute to the time it takes a cell to stop can be
modeled in a way similar to dynamic force spectroscopy experiments, where
the probability of bond breakage depends on the rate of dissociation for the
bond and the probability that it has not yet broken (76–78). Here, the
probability that a cell will firmly adhere in a small time (t, t þ dt) is equal
to the cellular association rate, kad, multiplied by the probability that the
cell did not yet firmly bind. Assuming the cellular association rate depends
on the adhesion molecule density, r, this leads to a probability of binding:
Padðr; tÞ ¼ kadðrðtÞÞ  exp
2
4
Zt
0
kad

r

t
0
dt
0
3
5: (A1)
The most probable time to stop, t*, is found when vPad=vt ¼ 0. Thus, the
integral of active integrin density over time to the stop point in the simula-
tions can be estimated by:
Zt
0
r

t
0
dt
0
: (A2)
For simplicity, we make the approximation that the active integrin
density is a linear function of time with rate constant kact:
rðtÞ ¼ kactt: (A3)
If the adhesion rate kad is a linear function of r, then it turns out that the
integral in Eq. A2 is constant with respect to kact. However, a slightlyBiophysical Journal 96(8) 2989–3004different form for kad may be appropriate. If kad is zero up to a minimum
time t1, then increases linearly with active integrin density:
kadðtÞ ¼ 0konðrðtÞ  rðt1ÞÞ
; t%t1
; t > t1
;

(A4)
the integral in Eq. A2 is no longer constant. Consider the case when the
minimum adhesion time, t1, decreases with the activation rate, kact, to
some nonzero minimum, tmin. This could be described by:
t1 ¼ tmin þ r0k1act: (A5)
It is reasonable that the minimum adhesion time itself has a minimum for
this model because an activated microvillus must reenter the contact zone
before having a chance to firmly bind. Furthermore, if a minimum number
of active integrins is required for firm adhesion, the minimum adhesion
time should decrease as the activation rate increases. With such a model
for t1, Fig. 12 shows that the integral in Eq. A2 reaches a minimum as a func-
tion of activation rate. Clearly, the adhesion rates are more complicated than
the simple approximations here, but this provides a possible explanation for
the minimum in the active integrin integral over rolling time (Fig. 5 A) as the
activation rate changes for different IL-8 densities.
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